Current Status of the Insecticide Resistance in Aedes aegypti (Diptera: Culicidae) from Mexico

The mosquito Aedes aegypti (Diptera: Culicidae) is the primary vector of dengue in Mexico and lately virus Chikungunya, although Aedes albopictus is widely distributed; its role in both diseases’ transmission has not been confirmed. The control of mosquitoes in Mexico includes source reduction consisting in the elimination of containers that are favorable sites for oviposition and development of the aquatic stage. The use of insecticides is to control larvae and adulticides as outdoor ultra-low volume applications and indoor residual spray and more recently impregnated materials. The health department regulates the use of insecticides, and such regulations are revised and adapted over time. Since 1999, the vector control regulations gave preference to the use of pyrethroids, a permethrin-based formulation to control adult forms. This insecticide was used as the only adulticide in Mexico for more than 10 years. The consequences of this actions have evolved in a widespread and strong resistance to other insecticides, mainly pyrethroids. We include in this revision evidence of resistance reported in Ae. aegypti in Mexico

Efficacy of long-lasting insecticidal nets with declining physical and chemical integrity on Aedes aegypti (diptera : culicidae)

Fitting long-lasting insecticidal nets (LLIN) as screens on doors and windows has a significant impact on indoor adult Aedes aegypti, with entomological reductions measured in a previous study being significant for up to two years post-installation, even in the presence of pyrethroid-resistant Aedes populations. The study used bioassays (0, 6, and 12 months), which confirmed that LLIN residual activity decreased over time. However, the study demonstrates that the remaining chemical effect after field conditions still contributes to killing/repelling mosquitoes. LLIN screening from the neighborhood Juan Pablo II in Merida (Yucatan State, Mexico) were randomly selected. Merida is highly endemic for dengue and other Aedes-borne viruses

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Reporte de consultoría

Reunión: Enfoques Ecosistémicos en Salud Humana, Enfermedades Transmitidas por Vector, Dengue y Tripanosomiasis Americana, 8-12 agosto 2005, Cuernavaca, M